Cargando…

Cell-free, high-density lipoprotein–specific phospholipid efflux assay predicts incident cardiovascular disease

BACKGROUND: Cellular cholesterol efflux capacity (CEC) is a better predictor of cardiovascular disease (CVD) events than HDL-cholesterol (HDL-C) but is not suitable as a routine clinical assay. METHODS: We developed an HDL-specific phospholipid efflux (HDL-SPE) assay to assess HDL functionality base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Masaki, Neufeld, Edward B., Playford, Martin P., Lei, Yu, Sorokin, Alexander V., Aponte, Angel M., Freeman, Lita A., Gordon, Scott M., Dey, Amit K., Jeiran, Kianoush, Hamasaki, Masato, Sampson, Maureen L., Shamburek, Robert D., Tang, Jingrong, Chen, Marcus Y., Kotani, Kazuhiko, Anderson, Josephine L.C., Dullaart, Robin P.F., Mehta, Nehal N., Tietge, Uwe J.F., Remaley, Alan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503808/ https://www.ncbi.nlm.nih.gov/pubmed/37471145 http://dx.doi.org/10.1172/JCI165370

Ejemplares similares

ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
por: Neufeld, Edward B., et al.
Publicado: (2019)

Effect of niacin monotherapy on high density lipoprotein composition and function
por: Gordon, Scott M., et al.
Publicado: (2020)

A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X
por: Neufeld, Edward B., et al.
Publicado: (2022)

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018)

Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
por: Anderson, Josephine L.C., et al.
Publicado: (2019)

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
por: Berg, Alexander R., et al.
Publicado: (2023)

A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross Linking
por: Jeiran, Kianoush, et al.
Publicado: (2022)

Voluntary exercise increases cholesterol efflux but not macrophage reverse cholesterol transport in vivo in mice
por: Meissner, Maxi, et al.
Publicado: (2010)

COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
por: Sorokin, Alexander V., et al.
Publicado: (2020)

Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux
por: Islam, Rafique M., et al.
Publicado: (2018)

Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults
por: Yang, Zhi-Hong, et al.
Publicado: (2020)

Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus—Brief Report
por: Apro, Johanna, et al.
Publicado: (2016)

Fasting Ketone Bodies and Incident Type 2 Diabetes in the General Population
por: Szili-Torok, Tamas, et al.
Publicado: (2023)

Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
por: Amar, Marcelo J. A., et al.
Publicado: (2016)

Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
por: Annema, Wijtske, et al.
Publicado: (2016)

Erratum to: Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
por: Amar, Marcelo J. A., et al.
Publicado: (2017)

Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study
por: Sorokin, Alexander V., et al.
Publicado: (2023)

Complex association of apolipoprotein E–containing HDL with coronary artery disease burden in cardiovascular disease
por: Sorokin, Alexander V., et al.
Publicado: (2022)

3065 A1BG and ITIH4 proteins are upregulated on HDL of youth with type 1 diabetes and correlate with glycemic control
por: Gourgari, Evgenia, et al.
Publicado: (2019)

FRI099 Advanced Lipoprotein Analysis In Patients With Cushing’s Syndrome
por: Varghese, Ron T, et al.
Publicado: (2023)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
por: Sorokin, Alexander V., et al.
Publicado: (2023)

The Human ABCG1 Transporter Mobilizes Plasma Membrane and Late Endosomal Non-Sphingomyelin-Associated-Cholesterol for Efflux and Esterification
por: Neufeld, Edward B., et al.
Publicado: (2014)

Molecular Mechanisms for Biliary Phospholipid and Drug Efflux Mediated by ABCB4 and Bile Salts
por: Morita, Shin-ya, et al.
Publicado: (2014)

Differential Effect of Dietary Supplementation with a Soybean Oil Enriched in Oleic Acid versus Linoleic Acid on Plasma Lipids and Atherosclerosis in LDLR-Deficient Mice
por: Yang, Zhi-Hong, et al.
Publicado: (2022)

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study
por: Gourgari, Evgenia, et al.
Publicado: (2019)

LCAT protects against Lipoprotein‐X formation in a murine model of drug‐induced intrahepatic cholestasis
por: Amar, Marcelo J. A., et al.
Publicado: (2019)

Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects
por: Dullaart, R. P. F., et al.
Publicado: (2016)

MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins
por: Vickers, Kasey C., et al.
Publicado: (2011)

Transbilayer Phospholipid Movements in ABCA1-Deficient Cells
por: Williamson, Patrick, et al.
Publicado: (2007)

Plasma angiopoietin-like 4 is related to phospholipid transfer protein activity in diabetic and non-diabetic subjects: role of enhanced low grade inflammation
por: Gruppen, Eke G., et al.
Publicado: (2018)

The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation
por: Ebtehaj, Sanam, et al.
Publicado: (2017)

Effect of metformin on the high‐density lipoprotein proteome in youth with type 1 diabetes
por: Gourgari, Evgenia, et al.
Publicado: (2021)

High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport
por: Anderson, Josephine L.C., et al.
Publicado: (2017)

Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus
por: Dullaart, Robin P. F., et al.
Publicado: (2019)

Enhanced Hepatic apoA-I Secretion and Peripheral Efflux of Cholesterol and Phospholipid in CD36 Null Mice
por: Yue, Pin, et al.
Publicado: (2010)

Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs
por: Barberio, Matthew D., et al.
Publicado: (2019)

Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies
por: Annema, Wijtske, et al.
Publicado: (2012)

Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen
por: Lucero, Diego, et al.
Publicado: (2021)

Low-Normal Thyroid Function and Novel Cardiometabolic Biomarkers
por: van Tienhoven-Wind, Lynnda J.N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3t7a6mejm10ghv2shnblc107l1